Kyle Mikson's Stock Ratings

Canaccord Genuity Analyst

Kyle Mikson is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/16/2024

Overall Average Return

-32.5%

Smart Score

32.4%

Overall Average Return Percentile

6th

Number of Ratings

49
Buy NowGet Alert
05/14/2024AKYABuy Now
Akoya Biosciences
$2.65126.42%$10 → $6MaintainsBuyGet Alert
05/10/2024NTRABuy Now
Natera
$107.3621.09%$100 → $130MaintainsBuyGet Alert
05/09/2024EXASBuy Now
Exact Sciences
$53.1759.86%$90 → $85MaintainsBuyGet Alert
04/29/2024TXGBuy Now
10x Genomics
$25.5895.47%$65 → $50MaintainsBuyGet Alert
04/29/2024TTOOBuy Now
T2 Biosystems
$5.90-49.15%$12 → $3MaintainsHoldGet Alert
04/29/2024QTRXBuy Now
Quanterix
$17.4543.27%$32 → $25MaintainsBuyGet Alert
04/29/2024GHBuy Now
Guardant Health
$25.9015.83%$45 → $30MaintainsBuyGet Alert
03/26/2024OLKBuy Now
Olink Holding
$23.779.4% → $26ReiteratesHold → HoldGet Alert
03/05/2024AKYABuy Now
Akoya Biosciences
$2.65277.36% → $10ReiteratesBuy → BuyGet Alert
03/04/2024BDSXBuy Now
Biodesix
$1.52129.51% → $3.5ReiteratesBuy → BuyGet Alert
02/29/2024NTRABuy Now
Natera
$107.36-6.86%$87 → $100MaintainsBuyGet Alert
02/23/2024GHBuy Now
Guardant Health
$25.9073.75%$50 → $45MaintainsBuyGet Alert
02/22/2024EXASBuy Now
Exact Sciences
$53.1769.27%$100 → $90MaintainsBuyGet Alert
12/07/2023BDSXBuy Now
Biodesix
$1.52129.51% → $3.5ReiteratesBuy → BuyGet Alert
11/27/2023NSTGBuy Now
NanoString Technologies
——$5 → $1.5MaintainsBuyGet Alert
11/10/2023ILMNBuy Now
Illumina
$114.694.63%$210 → $120DowngradeBuy → HoldGet Alert
10/31/2023PACBBuy Now
Pacific Biosciences
$2.14600.93%$17 → $15MaintainsBuyGet Alert
09/25/2023QSIBuy Now
Quantum-Si
$1.896.1%$3.5 → $2DowngradeBuy → HoldGet Alert
09/25/2023SLGCBuy Now
SomaLogic
—— → $2.5DowngradeBuy → HoldGet Alert
09/25/2023QTRXBuy Now
Quanterix
$17.4583.38%$25 → $32UpgradeHold → BuyGet Alert
09/19/2023TXGBuy Now
10x Genomics
$25.58173.65% → $70ReiteratesBuy → BuyGet Alert
09/19/2023NSTGBuy Now
NanoString Technologies
—— → $10ReiteratesBuy → BuyGet Alert
08/16/2023ILMNBuy Now
Illumina
$114.69148.5%$300 → $285MaintainsBuyGet Alert
08/16/2023VNRXBuy Now
VolitionRX
$0.78156.08%$3 → $2MaintainsOverweightGet Alert
07/06/2023ILMNBuy Now
Illumina
$114.69161.57% → $300ReiteratesBuy → BuyGet Alert
06/23/2023EXASBuy Now
Exact Sciences
$53.17116.29%$92 → $115MaintainsBuyGet Alert
06/21/2023EXASBuy Now
Exact Sciences
$53.1773.03% → $92ReiteratesBuy → BuyGet Alert
06/12/2023ILMNBuy Now
Illumina
$114.69161.57% → $300ReiteratesBuy → BuyGet Alert
06/06/2023CSTLBuy Now
Castle Biosciences
$24.7261.81%$60 → $40MaintainsBuyGet Alert
06/05/2023PACBBuy Now
Pacific Biosciences
$2.14694.39%$14 → $17MaintainsBuyGet Alert
05/04/2023TXGBuy Now
10x Genomics
$25.58154.1%$58 → $65MaintainsBuyGet Alert
03/29/2023SLGCBuy Now
SomaLogic
——$6 → $5MaintainsBuyGet Alert
02/24/2023GHBuy Now
Guardant Health
$25.90131.66%$65 → $60MaintainsBuyGet Alert
02/22/2023EXASBuy Now
Exact Sciences
$53.1741.06%$70 → $75MaintainsBuyGet Alert
02/16/2023TXGBuy Now
10x Genomics
$25.58126.74%$55 → $58MaintainsBuyGet Alert
01/17/2023ILMNBuy Now
Illumina
$114.69161.57%$330 → $300MaintainsBuyGet Alert
12/14/2022OLKBuy Now
Olink Holding
$23.7717.82% → $28Initiates → BuyGet Alert
11/16/2022PACBBuy Now
Pacific Biosciences
$2.14554.21%$12 → $14MaintainsBuyGet Alert
11/15/2022XGNBuy Now
Exagen
$1.93262.69%$8 → $7MaintainsBuyGet Alert
10/14/2022TTOOBuy Now
T2 Biosystems
$5.90-57.63%$1250 → $250DowngradeBuy → HoldGet Alert
08/15/2022QTRXBuy Now
Quanterix
$17.45-31.23% → $12DowngradeBuy → HoldGet Alert
05/13/2022SLGCBuy Now
SomaLogic
——$19 → $15MaintainsBuyGet Alert
04/13/2022NSTGBuy Now
NanoString Technologies
——$50 → $37MaintainsBuyGet Alert
04/05/2022CSTLBuy Now
Castle Biosciences
$24.72223.62%$94 → $80MaintainsBuyGet Alert
03/29/2022LUCDBuy Now
Lucid Diagnostics
$0.921204.35%$18 → $12MaintainsBuyGet Alert
03/24/2022NSTGBuy Now
NanoString Technologies
—— → $50Initiates → BuyGet Alert
02/16/2022PACBBuy Now
Pacific Biosciences
$2.141769.16%$45 → $40MaintainsBuyGet Alert
12/14/2021SLGCBuy Now
SomaLogic
———Initiates → BuyGet Alert
03/30/2021PAVMBuy Now
PAVmed
$1.95309.94% → $49.2Initiates → OverweightGet Alert

Recent Analyst Stock Rating News

Key Takeaways From Natera Analyst Ratings
Key Takeaways From Guardant Health Analyst Ratings
Cracking The Code: Understanding Analyst Reviews For Natera
Analyst Expectations For Guardant Health's Future
4 Analysts Have This To Say About Guardant Health
Analyst Ratings For Illumina
Deep Dive Into Illumina Stock: Analyst Perspectives (9 Ratings)
Why Illumina Inc Stock Is Falling
llumina, Inc. (NASDAQ: ILMN) shares are trading lower Friday after the company reported mixed third-quarter financial results on Thursday.
Synaptics To Rally Over 41%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Apple To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Tuesday
B of A Securities boosted the price target for Molson Coors Beverage Company (NYSE: TAP) from $54 to $68. B of A Securities analyst Bryan Spillane upgraded the stock from Underperform to Neutral. Molson Coors Beverage shares rose 2.1% to $65.15 in pre-market trading.
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free